• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

301
74
50
50
35

COUNTRY

34
12
12
11
11

PRICE

782
930
1,346
1,706

PUBLISHED

22
46
312
1,706

PRODUCT TYPE

1,104
499
85
16
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014

Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014’,...

July 2014
FROM

Cholera - Pipeline Review, H2 2014

Cholera - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cholera - Pipeline Review, H2 2014’, provides an overview of the Cholera’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted...

July 2014
FROM

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2014

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline...

June 2014
FROM

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014’, provides an overview of the H5N1 Infection...

June 2014
FROM

Anthrax - Pipeline Review, H1 2014

Anthrax - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anthrax - Pipeline Review, H1 2014’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM

Burkholderia Infections - Pipeline Review, H1 2014

Burkholderia Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H1 2014’, provides an overview of the Burkholderia Infections’s therapeutic...

June 2014
FROM

Warts - Pipeline Review, H1 2014

Warts - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Warts - Pipeline Review, H1 2014’, provides an overview of the Warts’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM

Bacterial Vaginosis - Pipeline Review, H1 2014

Bacterial Vaginosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bacterial Vaginosis - Pipeline Review, H1 2014’, provides an overview of the Bacterial Vaginosis’s therapeutic pipeline. This...

June 2014
FROM

Francisella Tularensis Infections - Pipeline Review, H1 2014

Francisella Tularensis Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Francisella Tularensis Infections - Pipeline Review, H1 2014’, provides an overview of the Francisella...

June 2014
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014’, provides an overview of the Hospital Acquired...

June 2014
FROM

Ebola and Marburg Infections - Pipeline Review, H1 2014

Ebola and Marburg Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ebola and Marburg Infections - Pipeline Review, H1 2014’, provides an overview of the Ebola and Marburg Infections’s...

June 2014
FROM

Tularaemia - Pipeline Review, H1 2014

Tularaemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Tularaemia - Pipeline Review, H1 2014’, provides an overview of the Tularaemia’s therapeutic pipeline. This report provides...

June 2014
FROM

Hepatitis D - Pipeline Review, H1 2014

Hepatitis D - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H1 2014’, provides an overview of the Hepatitis D’s therapeutic pipeline. This report provides...

June 2014
FROM

Shigella Infections (Shigellosis) - Pipeline Review, H1 2014

Shigella Infections (Shigellosis) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Shigella Infections (Shigellosis) - Pipeline Review, H1 2014’, provides an overview of the Shigella Infections...

June 2014
FROM

Adenovirus Infections - Pipeline Review, H1 2014

Adenovirus Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Adenovirus Infections - Pipeline Review, H1 2014’, provides an overview of the Adenovirus Infections’s therapeutic...

June 2014
FROM

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014’, provides an overview of the Genital...

June 2014
FROM

Plague - Pipeline Review, H1 2014

Plague - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Plague - Pipeline Review, H1 2014’, provides an overview of the Plague’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM

Hemorrhagic Fever - Pipeline Review, H1 2014

Hemorrhagic Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hemorrhagic Fever - Pipeline Review, H1 2014’, provides an overview of the Hemorrhagic Fever’s therapeutic pipeline. This...

June 2014
FROM

Anti-infectious Disease Drugs Markets in China

China's demand for Anti-infectious Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM
Loading Indicator

Our Clients

Our clients' logos